LATEST NEWS
Bristol Myers Squibb Reports Second Quarter 2020 Financial Results
–Bristol Myers Squibb (NYSE:BMY) today reports results for the second quarter of 2020, which reflect strong product sales, continued advancement of the pipeline and robust...
Read More
Guardant Health Guardant360® CDx First FDA-Approved Liquid Biopsy for Comprehensive Tumor Mutation Profiling Across All Solid Cancers
Guardant Health, Inc. (Nasdaq: GH) announces that the U.S. Food and Drug Administration (FDA) has approved Guardant360® CDx for tumor mutation profiling, also known...
Read More
Ancestry® Launches AncestryHealth® Powered by Next Generation Sequencing (NGS)
Ancestry®, the global leader in family history and consumer genomics, today announced the launch of AncestryHealth® powered by Next Generation Sequencing (NGS), signifying a...
Read More
Genetic testing for heart diseases may help patients and families identify risks
Genetic testing and counseling for inherited cardiovascular diseases may help patients and their families make well-informed decisions about managing their heart health, according to...
Read More
Konica Minolta Precision Medicine (KMPM) Launches Care for COVID Program
Ambry Genetics Corporation (Ambry), a leading clinical genetic testing laboratory, announced the launch of its CARE for COVID Program to provide employers with the...
Read More
Novartis announces Phase III study of Jakavi® in chronic graft-versus-host disease met primary and key secondary endpoints
Novartis today announced that the Phase III REACH3 study evaluating Jakavi® (ruxolitinib) in patients with steroid-refractory or steroid-dependent chronic graft-versus-host disease (GvHD) met its...
Read More
New post: Bristol Myers Squibb Reports Second Quarter 2020 Financial Results